{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:22:26Z","timestamp":1790270546376,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The novel coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, where the initial wave of intense community transmissions was cut short by interventions. Using multiple data sources, here we estimate the disease burden and clinical severity by age of COVID-19 in Wuhan from December 1, 2019 to March 31, 2020. Our estimates account for the sensitivity of the laboratory assays, prospective community screenings, and healthcare seeking behaviors. Rates of symptomatic cases, medical consultations, hospitalizations and deaths were estimated at 796 (95%\u00a0CI: 703\u2013977), 489 (472\u2013509), 370 (358\u2013384), and 36.2 (35.0\u201337.3) per 100,000 persons, respectively. The COVID-19 outbreak in Wuhan had a\u00a0higher burden than the 2009 influenza pandemic or seasonal influenza in terms of hospitalization and mortality rates, and clinical severity was similar to that of the 1918 influenza pandemic. Our comparison puts the COVID-19 pandemic into context and could be helpful to guide intervention strategies and preparedness for the potential resurgence of COVID-19.<\/jats:p>","DOI":"10.1038\/s41467-020-19238-2","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T07:19:17Z","timestamp":1603783157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China"],"prefix":"10.1038","volume":"11","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-8148","authenticated-orcid":false,"given":"Shengjie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-4749","authenticated-orcid":false,"given":"Marco","family":"Ajelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Viboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6335-5648","authenticated-orcid":false,"given":"Prof Hongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"19238_CR1","unstructured":"Johns Hopkins University. Coronavirus (COVID-19) Information and Updates. https:\/\/www.coronavirustraining.org\/live-map. Accessed 26 Jul 2020."},{"key":"19238_CR2","unstructured":"Centers for Disease Control and Prevention. Past Pandemics. https:\/\/www.cdc.gov\/flu\/pandemic-resources\/basics\/past-pandemics.html. Accessed 4 May 2020."},{"key":"19238_CR3","unstructured":"Health Commission of Hubei Province. Daily report on epidemic situation of COVID-19 in Hubei province. (in Chinese). http:\/\/wjw.hubei.gov.cn\/bmdt\/ztzl\/fkxxgzbdgrfyyq\/xxfb\/index.shtml. Accessed Jul 22 2020."},{"key":"19238_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2020.6130","volume":"323","author":"A Pan","year":"2020","unstructured":"Pan, A. et al. Association of public health interventions with the epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA 323, 1915\u20131923 (2020).","journal-title":"JAMA"},{"key":"19238_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1473-3099(20)30230-9","volume":"20","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Evolving epidemiology and transmission dynamics of novel coronavirus disease 2019 outside Hubei Province in China: a descriptive and modeling study. Lancet Infect. Dis. 20, 793\u2013802 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"19238_CR6","unstructured":"National Health Commission of China. The diagnosis and treatment scheme of novel coronavirus diseases 2019 (Trial version 5th). http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-02\/05\/content_5474791.htm. Accessed 25 Feb 2020."},{"key":"19238_CR7","unstructured":"National Health Commission of China. The diagnosis and treatment scheme of novel coronavirus diseases 2019 (Trial version 6th). http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-02\/19\/content_5480948.htm. Accessed 25 Feb 2020."},{"key":"19238_CR8","unstructured":"National Health Commission of China. The diagnosis and treatment scheme of novel coronavirus diseases 2019 (Trial version 7th). http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-03\/04\/content_5486705.htm. Accessed 3 Mar 2020."},{"key":"19238_CR9","unstructured":"Chinese Center for Disease Control and Prevention. Epidemic update and risk assessment of 2019 Novel Coronavirus. 2020. (in Chinese). http:\/\/www.chinacdc.cn\/yyrdgz\/202001\/P020200128523354919292.pdf. Accessed 31 Jan 2020."},{"key":"19238_CR10","unstructured":"The State Council of the People\u2019s Republic of China. Announcement of Wuhan Headquarters for the Control and Treatment of Novel Pneumonia (In Chinese). http:\/\/www.gov.cn\/xinwen\/2020-01\/24\/content_5472017.htm. Accessed 24 Jan 2020."},{"key":"19238_CR11","unstructured":"China Central Television. Report on results of 3-day screening in each district of Wuhan. (in Chinese). http:\/\/news.cctv.com\/2020\/02\/20\/ARTIfdQ2kV0eRTE4rgX2Aa3D200220.shtml. Accessed 20 Feb 2020."},{"key":"19238_CR12","doi-asserted-by":"publisher","first-page":"104346","DOI":"10.1016\/j.jcv.2020.104346","volume":"127","author":"A Xiao","year":"2020","unstructured":"Xiao, A. et al. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study. J. Clin. Virol. 127, 104346 (2020).","journal-title":"J. Clin. Virol."},{"key":"19238_CR13","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Health-seeking behaviors of patients with acute respiratory infections during the outbreak of novel coronavirus disease 2019 in Wuhan, China. Influenza Respir. Viruses 1\u20137 (2020).","DOI":"10.1101\/2020.05.05.20091553"},{"key":"19238_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/irv.12711","volume":"14","author":"L Feng","year":"2020","unstructured":"Feng, L. et al. Burden of influenza-associated outpatient influenza-like illness consultations in China, 2006\u20132015: a population-based study. Influenza Respir. Viruses 14, 162\u2013172 (2020).","journal-title":"Influenza Respir. Viruses"},{"key":"19238_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2213-2600(15)00278-7","volume":"3","author":"A Fowlkes","year":"2015","unstructured":"Fowlkes, A. et al. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009\u201313. Lancet Respir. Med. 3, 709\u2013718 (2015).","journal-title":"Lancet Respir. Med."},{"key":"19238_CR16","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1093\/cid\/ciq012","volume":"52","author":"SS Shrestha","year":"2011","unstructured":"Shrestha, S. S. et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009\u2013April 2010). Clin. Infect. Dis. 52, S75\u2013S82 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"19238_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/irv.12205","volume":"8","author":"H Yu","year":"2014","unstructured":"Yu, H. et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. Influenza Respir. Viruses 8, 53\u201365 (2014).","journal-title":"Influenza Respir. Viruses"},{"key":"19238_CR18","doi-asserted-by":"publisher","first-page":"e0221479","DOI":"10.1371\/journal.pone.0221479","volume":"14","author":"RS Palekar","year":"2019","unstructured":"Palekar, R. S. et al. Burden of influenza-associated respiratory hospitalizations in the Americas, 2010-2015. PLoS ONE 14, e0221479 (2019).","journal-title":"PLoS ONE"},{"key":"19238_CR19","doi-asserted-by":"publisher","first-page":"e0118369","DOI":"10.1371\/journal.pone.0118369","volume":"10","author":"C Reed","year":"2015","unstructured":"Reed, C. et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS ONE 10, e0118369 (2015).","journal-title":"PLoS ONE"},{"key":"19238_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","volume":"12","author":"FS Dawood","year":"2012","unstructured":"Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687\u2013695 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"19238_CR21","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1016\/S2468-2667(19)30163-X","volume":"4","author":"L Li","year":"2019","unstructured":"Li, L. et al. Influenza-associated excess respiratory mortality in China, 2010\u201315: a population-based study. Lancet Public Health 4, e473\u2013e481 (2019).","journal-title":"Lancet Public Health"},{"key":"19238_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"19238_CR23","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2307\/4575271","volume":"34","author":"WH Frost","year":"1919","unstructured":"Frost, W. H. The epidemiology of influenza. Public Health Rep. 34, 1823\u20131836 (1919).","journal-title":"Public Health Rep."},{"key":"19238_CR24","doi-asserted-by":"crossref","unstructured":"Mamelund S. E., Haneberg B., Mjaaland S. A Missed summer wave of the 1918\u20131919 influenza pandemic: evidence from household surveys in the United States and Norway. Open Forum Infect. Dis. 3, ofw040 (2016).","DOI":"10.1093\/ofid\/ofw040"},{"key":"19238_CR25","doi-asserted-by":"publisher","first-page":"e1000207","DOI":"10.1371\/journal.pmed.1000207","volume":"6","author":"AM Presanis","year":"2009","unstructured":"Presanis, A. M. et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 6, e1000207 (2009).","journal-title":"PLoS Med."},{"key":"19238_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/aje\/kwv054","volume":"182","author":"JY Wong","year":"2015","unstructured":"Wong, J. Y. et al. Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis. Am. J. Epidemiol. 182, 294\u2013301 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"19238_CR27","first-page":"759","volume":"69","author":"EK Stokes","year":"2020","unstructured":"Stokes, E. K. et al. Coronavirus disease 2019 case surveillance\u2014United States, January 22-May 30, 2020. MMWR 69, 759\u2013765 (2020).","journal-title":"MMWR"},{"key":"19238_CR28","doi-asserted-by":"crossref","unstructured":"Bignami S. & Assche A. V. Assessing the burden of COVID-19 in Canada. medRxiv. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.06.14.20130815v1 (2020).","DOI":"10.1101\/2020.06.14.20130815"},{"key":"19238_CR29","first-page":"458","volume":"69","author":"S Garg","year":"2020","unstructured":"Garg, S. et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019\u2014COVID-NET, 14 states, March 1\u201330, 2020. MMWR 69, 458\u2013464 (2020).","journal-title":"MMWR"},{"key":"19238_CR30","doi-asserted-by":"publisher","first-page":"m1923","DOI":"10.1136\/bmj.m1923","volume":"369","author":"JA Lewnard","year":"2020","unstructured":"Lewnard, J. A. et al. Incidence, clinical outcomes, and transmission dynamics of hospitalized 2019 coronavirus disease among 9,596,321 individuals residing in California and Washington, United States: a prospective cohort study. BMJ 369, m1923 (2020).","journal-title":"BMJ"},{"key":"19238_CR31","unstructured":"WHO-China Joint Mission. Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). https:\/\/www.chinadaily.com.cn\/pdf\/2020\/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 19 Mar 2020."},{"key":"19238_CR32","first-page":"12","volume":"38","author":"L Zheng","year":"2019","unstructured":"Zheng, L. Analysis and suggestion on the factors leading to the difficulty in the construction of hierarchical diagnosis system (In Chinese). Chin. Health Econ. 38, 12\u201315 (2019).","journal-title":"Chin. Health Econ."},{"key":"19238_CR33","doi-asserted-by":"crossref","unstructured":"New York City Department of health and mental hygiene (DOHMH) COVID-19 response Team. Preliminary estimate of excess mortality during the COVID-19 outbreak\u2014New York City, March 11\u2013May 2, 2020. MMWR 69, 603\u2013605 (2020).","DOI":"10.15585\/mmwr.mm6919e5"},{"key":"19238_CR34","doi-asserted-by":"publisher","unstructured":"Weinberger D. M. et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3391 (2020).","DOI":"10.1001\/jamainternmed.2020.3391"},{"key":"19238_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","volume":"26","author":"JT Wu","year":"2020","unstructured":"Wu, J. T. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 26, 506\u2013510 (2020).","journal-title":"Nat. Med."},{"key":"19238_CR36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1126\/science.abb6105","volume":"368","author":"H Tian","year":"2020","unstructured":"Tian, H. et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science 368, 638\u2013642 (2020).","journal-title":"Science"},{"key":"19238_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"19238_CR38","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"19238_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"S Henrik","year":"2020","unstructured":"Henrik, S. et al. Estimating the burden of SARS-CoV-2 in France. Science 369, 208\u2013211 (2020).","journal-title":"Science"},{"key":"19238_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3201\/eid2506.180532","volume":"25","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. Respiratory syncytial virus seasonality, Beijing, China, 2007\u20132015. Emerg. Infect. Dis. 25, 1127\u20131135 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"19238_CR41","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1128\/JCM.02258-09","volume":"48","author":"Z Zhang","year":"2010","unstructured":"Zhang, Z. et al. Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains. J. Clin. Microbiol. 48, 1201\u20131207 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"19238_CR42","doi-asserted-by":"publisher","first-page":"121392","DOI":"10.1016\/j.talanta.2020.121392","volume":"220","author":"E Sheikhzadeh","year":"2020","unstructured":"Sheikhzadeh, E., Eissa, S., Ismail, A. & Zourob, M. Diagnostic techniques for COVID-19 and new developments. Talanta 220, 121392 (2020).","journal-title":"Talanta"},{"key":"19238_CR43","doi-asserted-by":"crossref","unstructured":"Corman V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro. Surveill. 25, 2000045 (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"19238_CR44","doi-asserted-by":"publisher","first-page":"105980","DOI":"10.1016\/j.rmed.2020.105980","volume":"168","author":"J He","year":"2020","unstructured":"He, J. et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir. Med. 168, 105980 (2020).","journal-title":"Respir. Med."},{"key":"19238_CR45","doi-asserted-by":"publisher","first-page":"104416","DOI":"10.1016\/j.jcv.2020.104416","volume":"128","author":"L Bordi","year":"2020","unstructured":"Bordi, L. et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa\u2122 COVID-19 direct assay. J. Clin. Virol. 128, 104416 (2020).","journal-title":"J. Clin. Virol."},{"key":"19238_CR46","doi-asserted-by":"publisher","unstructured":"Lai, S. et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. https:\/\/doi.org\/10.1038\/s41586-41020-42293-x (2020).","DOI":"10.1038\/s41586-41020-42293-x"},{"key":"19238_CR47","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/S0140-6736(20)30746-7","volume":"395","author":"K Leung","year":"2020","unstructured":"Leung, K., Wu, J. T., Liu, D. & Leung, G. M. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet 395, 1382\u20131393 (2020).","journal-title":"Lancet"},{"key":"19238_CR48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(20)30744-3","volume":"395","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet 395, 1305\u20131314 (2020).","journal-title":"Lancet"},{"key":"19238_CR49","unstructured":"The State Council of the People\u2019s Republic of China. Press Conference of the Joint Prevention and Control Mechanism of the State Council. (In Chinese). http:\/\/www.gov.cn\/xinwen\/gwylflkjz48\/index.htm. Accessed 8 Mar 2020."},{"key":"19238_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(20)31278-2","volume":"396","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet 396, 63\u201370 (2020).","journal-title":"Lancet"},{"key":"19238_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","volume":"2","author":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team.","year":"2020","unstructured":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)\u2014China, 2020. China CDC Wkly 2, 113\u2013122 (2020).","journal-title":"China CDC Wkly"},{"key":"19238_CR52","doi-asserted-by":"publisher","unstructured":"Yang, J. et al. Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China. GitHub. https:\/\/doi.org\/10.5281\/zenodo.4014414 (2020).","DOI":"10.5281\/zenodo.4014414"},{"key":"19238_CR53","unstructured":"Health Commission of Hubei Province. The 20th press conference on prevention and control of pneumonia caused by novel coronavirus. (In Chinese). http:\/\/www.hubei.gov.cn\/hbfb\/xwfbh\/202002\/t20200210_2023490.shtml. Accessed 19 Sep 2020."},{"key":"19238_CR54","unstructured":"National Bureau of Statistics. China Statistic Yearbook. http:\/\/www.stats.gov.cn\/tjsj.\/ndsj\/. Accessed 3 Mar 2020."},{"key":"19238_CR55","unstructured":"China Health Commission. Chinese Health Statistical Yearbook (China Peking Union Medical College Press, in Chinese). http:\/\/navi.cnki.net\/KNavi\/YearbookDetail?pcode=CYFD&pykm=YSIFE&bh=. Accessed 11 Mar 2020."},{"key":"19238_CR56","unstructured":"The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 18 Mar 2020."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19238-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19238-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19238-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:42:34Z","timestamp":1670272954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19238-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19238"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19238-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.27.20183228","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A. has received research funding from Seqirus and H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. None of those research funding is related to COVID-19. All other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5411"}}